Regeneron Pharmaceuticals
Regeneron is seeking an Attack Surface & Vulnerability Management (ASVM) Analyst to support their cybersecurity efforts across various environments including on-premises, hybrid, and cloud. The role involves identifying, analyzing, and remediating vulnerabilities, ensuring security compliance, and collaborating with cross-departmental teams to strengthen the company's security posture.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Attack Surface Management Manager
Experian
Senior Security Analyst Consultant – Attack Surface Management
Kalles Group
Lead Analyst, Attack Surface Management (ASM)
University of Southern California
Attack Surface Management Manager
Experian
Vulnerability Management Analyst
Swiss Re Group
Senior Information Security Analyst – Attack Surface Management Function Lead
Mass General Brigham